Compound Summary
Compound Information
ellagic acid
Compound Name: | ellagic acid |
Compound CID: | 5281855 |
Synonyms: | ellagic acid 476-66-4 Benzoaric acid Elagostasine Lagistase More... |
Iupac Name: | 6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione |
InChI: | InChI=1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7)9(5)17)2-6(16)10(18)12(8)21-13(3)19/h1-2,15-18H |
InChIKey: | AFSDNFLWKVMVRB-UHFFFAOYSA-N |
Canonical Smiles: | C1=C2C3=C(C(=C1O)O)OC(=O)C4=CC(=C(C(=C43)OC2=O)O)O |
Isomeric Smiles: | C1=C2C3=C(C(=C1O)O)OC(=O)C4=CC(=C(C(=C43)OC2=O)O)O |
Molecular Weight: | 302.19 |
Molecular Formula: | C14H6O8 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
ellagic acid
Molecular Weight: | 302.19 |
Molecular Formula: | C14H6O8 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 8 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 22 |
Complexity: | 475 |
Synonyms
ellagic acid
| ellagic acid | ellagic acid |
|---|---|
ellagic acid |
476-66-4 |
Benzoaric acid |
Elagostasine |
Lagistase |
2,3,7,8-Tetrahydroxychromeno5,4,3-cdechromene-5,10-dione |
Eleagic acid |
Alizarine Yellow |
Gallogen |
Llagic acid |
Acide ellagique |
Acido elagico |
Acidum ellagicum |
C.I. 55005 |
C.I. 75270 |
Ellagicacid |
Ellagate |
UNII-19YRN3ZS9P |
Gallogen, astringent |
MLS000069632 |
C14H6O8 |
MFCD00006914 |
NSC407286 |
19YRN3ZS9P |
CHEMBL6246 |
SMR000058244 |
CHEBI:4775 |
4,4,5,5,6,6-hexahydroxydiphenic acid 2,6,2,6-dilactone |
2,3,7,8-Tetrahydroxy(1)benzopyrano(5,4,3-cde)(1)benzopyran-5,10-dione |
NSC656272 |
tetrahydroxy?dione |
NSC-407286 |
NSC-656272 |
NCGC00017245-02 |
DSSTox_CID_557 |
(1)Benzopyrano(5,4,3-cde)(1)benzopyran-5,10-dione, 2,3,7,8-tetrahydroxy- |
2,3,7,8-tetrahydroxy1benzopyrano5,4,3-cde1benzopyran-5,10-dione |
DSSTox_RID_75657 |
DSSTox_GSID_20557 |
Gallogen (VAN) |
Gallogen (astringent) |
Pomegranate juice |
1Benzopyrano5,4,3-cde1benzopyran-5,10-dione, 2,3,7,8-tetrahydroxy- |
Ellagic acid INN:DCF |
CAS-476-66-4 |
Acido elagico INN-Spanish |
CCRIS 774 |
Acide ellagique INN-French |
Acidum ellagicum INN-Latin |
SR-01000721925 |
EINECS 207-508-3 |
NSC 407286 |
NSC 656272 |
BRN 0047549 |
Benzoarate |
Ellagsaeure |
Polyphenolic |
Eleagate |
Ellagic |
Llagate |
ellagic-acid |
Elagic Acid |
HSDB 7574 |
2zjw |
REF |
Ellagic acid, 96% |
Spectrum_001194 |
Diphenic acid, 4,4,5,5,6,6-hexahydroxy-, di-delta-lactone |
Spectrum2_000905 |
Spectrum3_001535 |
Spectrum4_000750 |
Spectrum5_000959 |
Oprea1_032884 |
SCHEMBL20429 |
BSPBio_002950 |
KBioGR_001080 |
KBioSS_001674 |
5-19-07-00108 (Beilstein Handbook Reference) |
MLS006011868 |
BIDD:ER0482 |
BIDD:GT0565 |
SPECTRUM1502245 |
SPBio_000750 |
BDBM4078 |
LTK-20 |
DTXSID2020557 |
SCHEMBL19184504 |
BCBcMAP01_000154 |
cid_5281855 |
KBio2_001674 |
KBio2_004242 |
KBio2_006810 |
KBio3_002450 |
Ellagic acid, analytical standard |
HMS1921N20 |
HMS3673M09 |
Pharmakon1600-01502245 |
BCP10830 |
HY-B0183 |
TNP00132 |
ZINC3872446 |
Tox21_110805 |
6244AF |
BBL009292 |
CCG-36358 |
NSC758198 |
s1327 |
SBB006501 |
STK801964 |
Ellagic acid, >=96.0% (HPCE) |
2,3,7,8-Tetrahydroxy(1)benzopyrano(5,4,3-cde)-(1)benzopyran-5,10-dione |
AKOS004120045 |
Tox21_110805_1 |
CS-2067 |
DB08846 |
EBD2138595 |
NSC-758198 |
SDCCGMLS-0066664.P001 |
SMP1_000111 |
NCGC00017245-01 |
NCGC00017245-03 |
NCGC00017245-04 |
NCGC00017245-05 |
NCGC00017245-06 |
NCGC00017245-07 |
NCGC00017245-08 |
NCGC00017245-09 |
NCGC00017245-10 |
NCGC00017245-12 |
NCGC00094975-01 |
NCGC00094975-02 |
NCGC00094975-03 |
NCGC00094975-04 |
NCGC00178375-01 |
6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo6.6.2.04,16.011,15hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione |
AC-11647 |
AC-30710 |
AS-35095 |
NCI60_003869 |
ST057073 |
SBI-0051742.P002 |
AB0073029 |
E0375 |
Ellagic Acid, Dihydrate - CAS 476-66-4 |
FT-0603405 |
MLS-0066664.0001 |
AB00052292_11 |
AB00052292_12 |
A872094 |
Q422044 |
SR-01000721925-3 |
SR-01000721925-4 |
SR-01000721925-5 |
SR-01000721925-6 |
SR-01000721925-7 |
W-202834 |
BRD-K30466858-001-05-4 |
Ellagic acid, primary pharmaceutical reference standard |
Ellagic acid, >=95% (HPLC), powder, from tree bark |
Diphenic acid,4,5,5,6,6-hexahydroxy-, di-.delta.-lactone |
2,3,7,8-Tetrahydroxychromeno5,4,3-cdechromene-5,10-dione # |
Diphenic acid, 4,4,5,5,6,6-hexahydroxy-, di-.delta.-lactone |
1Benzopyrano5,3-cde1benzopyran-5,10-dione, 2,3,7,8-tetrahydroxy- |
2,3,7,8-Tetrahydroxy-1benzopyrano5,4,3-cde1benzopyran-5,10-dione |
2,3,7,8-TETRAHYDROXY-CHROMENO5,4,3-CDECHROMENE-5,10-DIONE |
2,3,7,8-Tetrahydroxy1benzopyrano-5,4,3-cde1benzopyran-5,10-dione |
1,2-dicarboxylic acid, 4,4,5,5,6,6-hexahydroxy-, di-.delta.-lactone" |
(1,1-Biphenyl)-2,2-dicarboxylic acid, 4,4,5,5,6,6-hexahydroxy-, di-.delta.-lactone |
122328-15-8 |
6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo6.6.2.0^{4,16}.0^{11,15}hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione |
6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo6.6.2.0^{4,16}.0^{11,15}hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione |
Experimental Data
ellagic acid
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 50 | umol/L | NS | N2 | 33683565 | Inactive | |||||||
| Caenorhabditis elegans | 300 | umol/L | S | N2 | 33683565 | ||||||||
| Caenorhabditis elegans | 200 | umol/L | NS | N2 | 33683565 | Inactive | |||||||
| Caenorhabditis elegans | 50 | umol/L | S | N2 | 33683565 | ||||||||
| Caenorhabditis elegans | 100 | umol/L | NS | N2 | 33683565 | Inactive | |||||||
| Caenorhabditis elegans | 25 | umol/L | NS | N2 | 33683565 | Inactive | |||||||
| Caenorhabditis elegans | 50 | umol/L | 27 | 29 | 0.07 | S | N2 | 21805983 | Active | ||||
| Caenorhabditis elegans | 50 | umol/L | -4.3 | NS | N2 | 33683565 | Inactive | ||||||
| Caenorhabditis elegans | 50 | umol/L | -4.3 | NS | N2 | 27400265 | Inactive | ||||||
| Drosophila melanogaster | 10 | % | 40.5 | 48 | 18.51 | S | Canton-S | MALES | 25566518 | Active | |||
| Drosophila melanogaster | 10 | % | 43.5 | 47 | 8 | S | Canton-S | FEMALES | 25566518 | Active | |||
| Drosophila melanogaster | 0.1 | % | 40.5 | 42 | 3.7 | NS | Canton-S | MALES | 25566518 | Inactive | |||
| Drosophila melanogaster | 0.1 | % | 43.5 | 43 | -1.14 | NS | Canton-S | FEMALES | 25566518 | Inactive | |||
| Drosophila melanogaster | 1 | % | 40.5 | 42 | 3.7 | NS | Canton-S | MALES | 25566518 | Inactive | |||
| Drosophila melanogaster | 5 | % | 43.5 | 44 | 1.14 | NS | Canton-S | FEMALES | 25566518 | Inactive | |||
| Drosophila melanogaster | 5 | % | 40.5 | 42 | 3.7 | NS | Canton-S | MALES | 25566518 | Inactive | |||
| Drosophila melanogaster | 1 | % | 43.5 | 43.5 | 0 | NS | Canton-S | FEMALES | 25566518 | Inactive |
Experimental Data Visualization
ellagic acid
Statistics Data
ellagic acid
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 0.07 | 3 | 9 | |
| Drosophila melanogaster | 18.51 | 1 | 8 |
Statistics Data Visualization
ellagic acid
